Funders to approach for MLD Foundation
MLD Foundation works with families, researchers, regulators, industry, and policy-makers to improve the quality of life for those with MLD including standards of clinical care and clinical research excellence, develop and implement newborn screening tests and policies, develop and improve therapies for MLD, and influence & fund research for a cure. Metachromatic leukodystrophy (MLD) is a rare genetic neuro-metabolic degenerative terminal condition affecting people, predominantly infants and children, throughout the world. Our slogan, "We C.A.R.E."(R) reflects our mission of Compassion, Awareness, Research, and Education. Today there are no adequate therapies in the US and there is no cure. Clinical care and diagnostics including newborn screening, are improving but have much more to improve upon. The MLD Foundation was formed in May 2001 and serves newly diagnosed families as well as those at all stages of the MLD journey in the US and…
Your prospects by chance and grant size
a funder to approach
Half the value is in your top 4 funders, of 158
- 1Global GenesSimilar grantees: The Marfan Foundation Inc ($15k/yr), Lhon Collective ($9k/yr), The Fibrous Dysplasia Foundation ($7k/yr)1 in 19$10k
- 2Pharmaceutical Research and Manufacturers of AmericaSimilar grantees: Global Down Syndrome Foundation ($30k/yr), MTS Sickle Cell Foundation ($6k/yr), National Organization for Rare Disorders Inc ($11k/yr)under 1 in 100$17k
- 3Matthew Larson Foundation for PediatricNo similar grantees yetunder 1 in 100$62k
155 more funders on the list for MLD Foundation
The full ranking, every way in, an approach plan for each funder and the CSV are included from the $75 plan up.